3/19/18. Medications Used In the Mental Health Care of Children. General Pediatric Psychopharmacology Overview

Size: px
Start display at page:

Download "3/19/18. Medications Used In the Mental Health Care of Children. General Pediatric Psychopharmacology Overview"

Transcription

1 Medications Used In the Mental Health Care of Children American Academy of Pediatrics Critical Issues in School Health March 22 nd 2018 Jennifer Zajac, D.O. Saachi Tarr, M.D. Vanessa Katon, D.O. Institute of Living/ Hartford Hospital General Pediatric Psychopharmacology Overview Psychopharmacology studies are limited in children. Off label use of medications common Children metabolize differently Developmental Aspects of Medication Management in Pediatric Population Basic pharmacokinetic processes are absorption, distribution, metabolism, and excretion: Children have smaller body size, but greater proportion of liver/kidney parenchyma when adjusted to body weight They have more body water, less fat, and less plasma albumin 1

2 Developmental Aspects of Medication Management in Pediatric Population Because of these differences in children compared to adults: There is smaller volume of distribution for drugs (higher risk for sensitivities because of higher peak plasma concentrations) Greater drug extraction during 1 st pass metabolism (less drug that actually makes it to metabolism phase) Lower bioavailability (less drug available to utilize) Faster metabolism and elimination of the drug Developmental Aspects of Medication Management in Pediatric Population This leads typical Start Low and Go Slow prescribing to avoid potential for sensitivities. However, because of faster metabolism, etc. it is common to prescribe at higher dosages and/or more frequent dosing schedules to achieve optimum benefits. Antidepressants Several different types of antidepressants: SSRIs (Selective Serotonin Reuptake Inhibitors) SNRIs( Serotonin-Norepinephrine Reuptake Inhibitors) MAOIs (Monoamine Oxidase Inhibitors) TCAs (Tricyclic antidepressants) Other: Wellbutrin, Mirtazapine 2

3 Antidepressants: SSRIs SSRIs are a group of antidepressants that selectively inhibit serotonin reuptake First-line to treat depression and anxiety Require minimum of 4-6 weeks to discern maximum benefit of current dose Commonly Used SSRIs Citalopram (a.k.a. Celexa) Typical starting dose 5-10 mg daily Typical Dosage Range mg daily Not FDA approved in children Commonly used to treat: Social phobia, depression, GAD Lexapro (a.k.a. Escitalopram) Typical starting dose 5-10 mg daily Typical dosing range mg daily FDA approved for MDD in ages 12 and up Also commonly used to treat anxiety symptoms Commonly Used SSRIs Fluoxetine (a.k.a. Prozac) Typical starting dose 10 mg daily (AM) Typical dosing range mg daily (AM) FDA approved to treat MDD in ages 8 and up Also used to treat OCD, GAD, Separation Anxiety, Social Phobia Known CYP450 2D6 inhibitor-can impact metabolism of any other medication processed by this enzyme Long half-life Paroxetine (a.k.a. Paxil) Typical starting dose 10 mg daily Typical dosing range mg daily Not FDA approved in pediatrics Less frequently used given significant withdrawal side effects quickly after abrupt cessation May still be seen at times to treat depression, Separation Anxiety, and Social Anxiety 3

4 Commonly Used SSRIs Fluvoxamine (a.k.a Luvox) Typical starting dose 25 mg daily Typical dosing range mg daily More rare to see used in this population, but may come across this medication for treatment of OCD, GAD, Separation Anxiety, and Social Anxiety in select few Sertraline (a.k.a. Zoloft) Typical starting dose mg daily Typical dosing range mg daily (some young people require as high as 300 mg however) Commonly used to treat depression, OCD, Panic Disorder Side Effects of SSRIs Typically SSRIs are very well tolerated Most often, any side effects experienced typically subside with time and/or reduction in dosage and/or change in dosing frequency More common side effects experienced include: GI upset (e.g. nausea/vomiting) Insomnia (e.g. Fluoxetine) Sedation (e.g. Paroxetine, Fluvoxamine) Anxiety/Agitation ( e.g. Fluoxetine) Headache Side Effects of SSRIs Rare but more serious side effects include: Serotonin Syndrome Increased suicidality (a.k.a. Black Box warning) 4

5 Serotonin Syndrome Hyperthermia Muscle Rigidity Myoclonus Tremors Agitation Confusion Rare if SSRI taken as prescribed Can occur in: overdose, taking SSRI with another serotonergic agent, recent MAOI use Black Box Warning FDA issued public warning indicating individuals younger than 25 years of age treated with an antidepressant are at increased risk of suicidal thoughts or behavior. However, review of evidence still suggests that benefits of antidepressant medications likely outweigh their risks to children and adolescents with major depression and anxiety disorders If increase suicidal behavior is to be observed in relation to antidepressants, it is most likely to occur following initiation or dosage increase. Antidepressants: SNRIs Selectively inhibit serotonin and norepinephrine reuptake Require minimum of 4-6 weeks to discern maximum benefit of current dose Often 2 nd or 3 rd in line to treat anxiety and depressive disorders Can be beneficial in treating symptoms of anhedonia/low motivation related to depression 5

6 Commonly Used SNRIs Venlafaxine (a.k.a. Effexor) Typical starting dose 37.5 mg q AM Typical dosing range mg q AM Frequently used to treat Social Anxiety, GAD, Separation Anxiety, and depression Typically prescribed in XR formulation, but may occasionally see short acting formulation requiring BID dosing Desvenlafaxine (a.k.a. Pristiq) Typical starting dose 25 mg daily Typical dosing range mg daily Not yet FDA approved in pediatrics population, but used to treat depression and anxiety disorders Duloxetine (a.k.a. Cymbalta) Typical starting dose mg q AM Typical dosing range mg q AM Not FDA approved in pediatric population; may more commonly see this prescribed in individuals suffering from pain issues (e.g. fibromyalgia) May see used to treat anxiety and depressive disorders Side Effects of SNRIs Most often, any side effects experienced typically subside with time and/or reduction in dosage and/or change in dosing frequency SNRIs can be very well tolerated and potential side effects overlap with those of SSRIs, but due to increase in NE, there is less likely to be sedation. More common side effects experienced include: GI upset (e.g. nausea/vomiting) Insomnia Anxiety/Agitation Headache Side effect of SNRIs Due to increases in NE from the selective reuptake of SNRIs, individuals may also experience: Increased blood pressure Tachycardia Reduced appetite and associated weight loss 6

7 Antidepressants: Tricyclics (TCAs) Tricyclic Antidepressants Less commonly used in pediatric populations due to anticholinergic effects and cardiac risks in overdose. It is advised to get baseline ECG and periodic ECG when taking these medications. Clomipramine Typical dosing range mg/kg daily Used to treat OCD Imipramine Typical dosing range mg/kg daily Used to treat GAD, Panic Disorder, Nocturnal Enuresis Side Effects of TCAs 7

8 Antidepressants: MAOIs Through the inhibition of Monoamine Oxidase, serotonin, norepinephrine, and dopamine are increased. Old class of medications used to treat depression and anxiety Monoamine Oxidase Inhibitors are very rarely ever used in pediatric population due to their known number of potential side effects including risk of hypertensive crisis from excess tyramine build up. A special diet is required. Antidepressants: Other Bupropion (a.k.a. Wellbutrin SR & Wellbutrin XR) Some minimal impact on SE and NE levels as well impact on increasing DA Used to treat depressive disorders, smoking cessation, ADHD Typical starting dose SR & XR formulations 100 mg q AM & 150 mg q AM) Dosing ranges: Wellbutrin SR mg BID Wellbutrin XR mg q AM Antidepressants: Other Mirtazapine (a.k.a. Remeron) Dosing ranges between mg Not FDA approved in pediatric population Acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors. Because of its strong sedative effects, often given at night and may be prescribed to assist in sleep difficulties 8

9 Antidepressants Mood Stabilizing Agents Medications with mood stabilizing properties include atypical antipsychotics, antiepileptics, and lithium. Mood stabilizers are used to treat bipolar mania/depression, augment unipolar depression, as well as potentially be used in other circumstances of disruptive/aggressive behavior (e.g. DMDD) Mood Stabilizing Agents: Lithium Lithium is FDA approved in children over 12 years of age for Bipolar mania and maintenance. Also can be used to augment in depression One of two medications known to reduce suicidality Mechanism of action unknown exactly and overall complex but includes: Alteration in sodium transport across cell membranes Alteration of neurotransmitters including catecholamines and serotonin 9

10 Mood Stabilizing Agents: Lithium Typical dose range mg/kg/day Often started around mg daily and titrated by mg every 5-7 days. Maximum dosing 1800 mg/day Typically divided in BID or even TID dosing Narrow therapeutic window ( ) Excessive sweating, vomiting, diarrhea all could impact lithium level and lead to toxicity NSAIDs should be avoided (only acetaminophen) Frequent blood draws upon initiation and then every 3-6 months once stable level achieved Lithium level TSH/T4 Electrolytes including Ca Renal Panel Side Effects of Lithium Common side effect associated with Lithium include: Weight gain Tremor Acne Increased thirst Polyuria Hypothyroidism/Euthyroid/Goiter Sedation Lithium Toxicity Ataxia Confusion Renal failure Cardiac arrhythmia Significant tremor Vomiting Is deadly if not treated; Lithium should be stopped immediately if toxicity occurs 10

11 Mood Stabilizing Anti-epileptics Carbamazepine (a.k.a. Tegretol) Typical dosing range 400-1,200 mg/day; mg/kg/day if under the age of 6 years Used to treat seizure disorders, some pain syndromes, Bipolar Disorder/Mood lability Acts through voltage gated sodium channels to inhibit release of glutamate Induces its own metabolism through CYP450 3A4 enzyme often requiring upward dose adjustment of itself, but also potentially any other medications metabolized through this enzyme. Baseline labs and periodically Common side effects include: Sedation Dizziness GI upset Blurred vision Benign leukopenia-transient in up to 10% Rash-not to be confused with Steven s Johnson s Weight gain can occur but less associated than other agents Mood Stabilizing Anti-epileptics More rare but life-threatening side effects include: Aplastic anemia Unusual bleeding and bruising Mouth sores Fever Sore throat Infections Severe skin reactions (e.g. Steven s Johnson s) Fever Unexplained widespread skin pain A red or purple skin rash that spreads Blisters on your skin and the mucous membranes of mouth, nose, eyes and genitals Shedding of your skin within days after blisters form Generalized flu-like symptoms SIADH w/ associated hyponatremia Mood Stabilizing Anti-epileptics Valproate (a.k.a. Depakote, Depakene, Depakote ER) Typical dosing range mg/kg/day MOA largely unknown but believed to work through voltage-sensitive sodium channels as well as having mechanism to increase GABA Used to treat seizure disorders, Bipolar Disorder/Mood lability, and aggressive/disruptive behaviors Baseline labs and routine monitoring of Platelet counts, LFTs, Lipids, Ammonia, Depakote Level 11

12 Mood Stabilizing Anti-epileptics Depakote side effects more commonly include: Sedation Weight gain and associated metabolic syndrome GI upset Controversial, less common side effects include: Alopecia, PCOS, Decreased Bone Density Frequently given as BID or even TID dosing to avoid SE Mood Stabilizing Anti-epileptics Rare but more life-threatening side effects of Depakote include: Hepatotoxicity Pancreatitis Elevated Ammonia Mood Stabilizing Anti-epileptics Lamotrigine (a.k.a. Lamictal) Typical dosing roughly 4.5 mg/kg/day Requires very slow titration to avoid potential risk of Steven s Johnsons Attenuates glutamate release via Na+, K+, and Ca+2 channels Used to treat seizure disorders, Bipolar Disorder, augment in MDD Fairly well tolerated: Does not require lab monitoring Not typically associated with weight gain or sedation Side effect most commonly associated but is very rare with proper titration is Steven s Johnsons Syndrome. Pediatric population at higher risk, but still very rare Along with severe rash, associated with multi-organ failure If purpuric, widespread, tender rash with systemic sx develops-stop Lamictal, go to ED 12

13 Mood Stabilizing Anti-epileptics Oxcarbamazepine (a.k.a. Trileptal) Frequently further down the line with less evidence to support mood stabilizing properties; off-label in kids Benefits include minimal need for lab monitoring Some increased risk for hyponatremia that may check Na+ levels every 3-6 months Generally well tolerated in terms of levels of sedation and weight gain Some association with drug rashes including Stevens- Johnsons, but very rare Mood Stabilizing Anti-epileptics Topiramate (a.k.a. Topamax) Little evidence to truly support its use as a mood stabilizer, but may be still be used as adjunctive treatment for mood stabilization Takes several weeks to discern if benefits can be seen More likely to see this used in seizure disorders, migraine prophylaxis, bingeeating, and weight management Common side effects include: Appetite suppression Sedation Blurred and/or double vision Confusion Memory problems Psychomotor retardation General fatigue Increased risk for kidney stones ADHD Medications used to treat inattentive behavior hyperactivity explosively irritability impulsivity Medication types: Stimulants, alpha agonists, stimulant like medications 13

14 Role of treatment Help improve attention, focus, and concentration Decrease hyperactivity, fidgeting, and impulsivity May increase academic performance and peer interactions Improve peer relationships Variety of formulations Formulations of pills: IR = Immediate Release XR = Extended Release ER = Extended Release SR = Sustained Release LA = Long-Acting CD = Controlled-Dispense Liquid Patches Alpha-2-Adrenergic Agonists (Alpha-2-agonists) Also used: tic disorders, substance withdrawal, ADHD, PTSD, social anxiety, irritability, and situations that include anxiety and impulsivity. Traditionally used to treat HTN. Clonidine (IR) Typical starting dose 0.05 mg q HS Typical dosing range mg/day in divided doses Works centrally on post-synaptic alpha 2 receptors in the prefrontal cortex Clonidine HCL extended release tablets (ER) (commercially: Kapvay) Clonidine Patch qweekly though can be more frequent, during titration may briefly have oral dose 14

15 Alpha-2-Adrenergic Agonists (Alpha-2-agonists) Guanfacine IR (aka Tenex) More selectivity at alpha receptors such that sedation frequent. Similar side effect profile otherwise Regular monitoring of blood pressure recommended Typical starting dose 0.05mg Dose range 0.05mg-2mg/day in divided doses (daily, BID, 4x day) Guanfacine ER (aka Intuniv) Typical starting dose: 0.05mg Dose Range 0.05mg-4mg (though can be higher) Side Effects Alpha-2-agonists Constipation Sedation or fatigue Low blood pressure Low heart rate Fever Weakenss Nausea and vomiting Nervousness or agitation Headache High-blood pressure if med suddenly discontinued (without tapering off) Long-acting formulations may cause dry mouth and require student to drink plenty of water Stimulants Modulate NE and dopamine levels in the CNS Two broad categories: Amphetamine Derivatives Methylphenidate Derivatives Quick Response Can make quicker dose adjustments No withdrawal from missed doses 15

16 Stimulants Stimulants Methylphenidate Long Acting Concerta Daytrana Patch Intermediate Acting Metadata ER Metadata CD Ritalin LA Ritalin SR Short Acting Methylin (liquid or chewable) Quillivant XR (liquid available) Ritalin 16

17 Amphetamine Derivatives Short Acting Evoke Zenzedi Adderall ProCentra (liquid) Long Acting/ER Vyvanse (can remixed with yogurt/oj/water) Adderall XR (capsule can be opened and sprinkled on applesauce) Dexedrine Spansule Focalin - short-acting Focalin XR long-acting psules_novartis.html Notes on Stimulants Can have XR then IR dosing Can have IR BID dosing Can have XR BID dosing May have stimulant + alpha-2-agonist combination High abuse potential Stimulant can be stopped suddenly alpha-2-agonist MUST TITRATE 17

18 Daytrana Patch Newer formulation-transdermal Available: 10/15/20/30mg patch Patch should not be on more than 9 hours Dose can be adjusted by length of patch use Do not reapply used patch Generally apply to hip Alternate hip each day and rotate sites Stimulant Side Effects Anxiety Decreased appetiteà weight loss à delayed growth Pediasure Diarrhea or constipation HTN Tachycardia Dizziness Dry mouth Irritability Nausea Headache Trouble sleeping Possible worsening of tics Rash (Daytrana patch) Paranoia/psychosis Rarely: arrhythmia Non-stimulant Atomoxetine (aka Strattera) Mechanism of Action: Unclear,? inhibition of presynaptic norepinephrine re-uptake in the prefrontal cortex Small changes within 2 weeks 4-6 weeks to see significant improvements May help improve attention and reduce hyperactivity/impulsivity The most common side effects include: Constipation Dry mouth Nausea Decreased appetite Dizziness Problems urinating Low abuse potential 18

19 Anti-psychotics Used for: aggression, augmentation for depression or anxiety treatment, irritability, psychosis, Bipolar DO, OCD, behaviors related to autism One of the first categories of psychiatric medications: Chlorpromazine (1950) Dosage can be divided throughout the day Two Broad Categories Side Effects First Generation AP Chlorpromazine, Haloperidol, Perphenazine in children (Thorazine/Haldol/Trilafon) Anticholinergic: constipation, blurred vision, dry mouth, urinary retention Antihistaminic: Sedation Anti alpha 1: orthostatic hypotension Hyperprolactonemia- Galatorrhea/Gynecomastia Extrapyramidal Side Effects (EPS) Also risk for QTc prolongation 19

20 EPS Hours to days: Acute dystonia (sustained muscle contraction), tremor Laryngeal dystonic reaction!! Days to weeks: Akathisia (inner feeling not restlessness, very disturbing) Weeks to months/years: Parkinsonism, Tarydive Dyskinesia Side Effects Second Generation Antipsychotics Risperidone, Aripiprazole, Quetiapine, Ziprasidone May have SE of typical AP but rarer Increased risk for Metabolic Syndrome: weight increase, particularly abdominal girth hyperlipidemia Increase insulin resistance Diabetes Mellitus Sedation/Fatigue Sometimes Activating/increase irritability Risperidone: Hyperprolactinemia Dosage ranges substantially vary: Risperidone 0.25mg - 6mg daily, Quetiapine 12.5mg to 900mg daily Neuroleptic Malignant Syndrome 20

21 Long Acting Injectables IM delivery of antipsychotics Slow release allows for qweekly to q 3 monthly dosing Individuals with significant psychosis Both Typical and Atypical Antipsychotics May have overlap with oral medications during initiation of injectable Once steady state is reached, no more oral medications Increases compliance Risk of same side effects Miscellaneous May come across other medications used to treat mental health disorders. Prazosin o Prescribed to address trauma symptoms: nightmares, flashbacks, hypervigilance o Typically given at night o May cause hypotension Hydroxyzine (a.k.a. Vistaril) o May see as scheduled or PRN for episodes of anxiety in conjunction with other anxiolytic medications Buspirone (a.k.a. Buspar) o BID, TID dosing o May be used to address anxiety Benzodiazepines (e.g. Lorazepam, Clonazepam) o Regular, long-term use typically avoided o Potential for abuse, tolerance, and dependence o Sometimes prescribed scheduled and/or PRN for acute agitation episodes, panic episodes, or for catatonia Trazodone o Typically prescribed mg q HS to address sleep issues o However, not FDA approved for sleep and is only FDA approved for MDD in adults Benadryl o May be prescribed as PRN for acute agitation or sleep o Ideally would avoid long-term use due to sedation and anticholinergic effects Miscellaneous Trazodone o Typically prescribed mg q HS to address sleep issues o However, not FDA approved for sleep and is only FDA approved for MDD in adults Benadryl o May be prescribed as PRN for acute agitation or sleep o Ideally would avoid long-term use due to sedation and anticholinergic effects 21

22 Take Home Points Children metabolize medications differently Medication Emergencies: Serotonin Syndrome NMS Laryngeal Spasm ADHD treatment varies a great deal Important to keep an eye on vital signs Also include psychiatric vital signs: worsening irritability, increase in depression Bibliography Diagnostic And Statistical Manual of Mental Disorders : DSM-5. Arlington, VA :American Psychiatric Publishing, Print. North Shore LIJ, Children s Medical Center NY ADHD Medication Guide Chart. Stahl, Stephen M. Stahl s Essential Psychopharmacology: Neuroscientific Basis and Practical Application. Cambridge University Press, Stahl, Stephen M. The Prescriber's Guide: Stahl's Essential Psychopharmacology. Cambridge University Press, Zajac, Jennifer. ADHD Medications 4 Dec PowerPoint File. 22

Schedule FDA & literature based indications

Schedule FDA & literature based indications Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting

More information

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

Quick Guide to Common Antidepressants-Adults

Quick Guide to Common Antidepressants-Adults Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa

More information

Children s Hospital Of Wisconsin

Children s Hospital Of Wisconsin Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,

More information

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

Psychiatric Medication Guide

Psychiatric Medication Guide Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants

More information

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150

More information

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center

Evidence-Based Pharmacotherapy. Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center Evidence-Based Pharmacotherapy Emily Harris, MD, MPH, FAAP Cincinnati Children s Hospital Medical Center CME Disclosure I have no personal financial relationships in any commercial interest related to

More information

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6 in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,

More information

Child & Adolescent Psychiatry (a brief overview)

Child & Adolescent Psychiatry (a brief overview) Child & Adolescent Psychiatry (a brief overview) Lance Feldman, MD, FAPA, MBA, BSN Vice Chair Clinical Affairs, Department of Psychiatry Affiliate Clinical Assistant Professor, University of South Carolina

More information

Creating Partnerships. Laine Young-Walker, MD

Creating Partnerships. Laine Young-Walker, MD Creating Partnerships Laine Young-Walker, MD Psychiatry is the medical specialty devoted to the study, diagnosis, treatment and prevention of mental disorders. Medical school >>>four years of residency

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

Psychiatry in Primary Care: What is the Role of Pharmacist?

Psychiatry in Primary Care: What is the Role of Pharmacist? Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure

More information

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center

Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Managing the Behavior Problems of Children With Fragile X Syndrome by Using Medication Ave M. Lachiewicz, MD, Duke University Medical Center Abstract: The majority of boys and many girls with fragile X

More information

Anti-Depressant Medications

Anti-Depressant Medications Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change

More information

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty

More information

Presentation is Being Recorded

Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

ANTI-DEPRESSANT MEDICATIONS

ANTI-DEPRESSANT MEDICATIONS ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change

More information

Drugs for Emotional and Mood Disorders Chapter 16

Drugs for Emotional and Mood Disorders Chapter 16 Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,

More information

AD/HD is a mental disorder, and it often lasts from

AD/HD is a mental disorder, and it often lasts from short version10 WHAT WE KNOW Managing Medication for Adults with AD/HD AD/HD is a mental disorder, and it often lasts from childhood into adulthood. Medication is the basic part of treatment for adults.

More information

Depression & Anxiety in Adolescents

Depression & Anxiety in Adolescents Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with

More information

Mood Disorders.

Mood Disorders. Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner

More information

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S. BRIEF ANTIDEPRESSANT OVERVIEW Casey Gallimore, Pharm.D., M.S. Antidepressant Medication Classes First Generation Tricyclic Antidepressants (TCAs) Monoamine Oxidase Inhibitors (MAOIs) Second Generation

More information

PL CE LIVE February 2011 Forum

PL CE LIVE February 2011 Forum February 2011 PL CE LIVE Kristin W. Weitzel, Pharm.D., CDE, FAPhA Associate Editor and Director of Editorial Projects Pharmacist s Letter/Prescriber s Letter Atypical Antipsychotics Atypical Antipsychotics

More information

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY 13 th Pearl Leibovitch Clinical Day November 18th, 2014 Mounir H. Samy, MD, FRCP(C) Associate Professor of Psychiatry McGill University (ret.) FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD

More information

ADHD Medications: Basics. David Benhayon MD, PhD

ADHD Medications: Basics. David Benhayon MD, PhD ADHD Medications: Basics David Benhayon MD, PhD Goals & Objectives Understand basic classes of stimulants and equivalents Be exposed to role of nonstimulant alternatives Discuss the role of therapy in

More information

PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES

PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14

More information

3. Atypical antidepressants

3. Atypical antidepressants 3. Atypical antidepressants Bupropion, mirtazapine, nefazodone & trazodone. Mixed group that act at several different sites. Bupropion Acts as a weak dopamine & NE reuptake inhibitor. Has short half-life.

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

Things You Might Not Know About Psychotropic Medications But Wish You Did

Things You Might Not Know About Psychotropic Medications But Wish You Did Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)

More information

Dose Range. Dose Schedule. Child: 5-60 mg Over 50 kg:5-100 mg Focalin, child: mg Over 50 kg: mg. Focalin: 4-5 hrs.

Dose Range. Dose Schedule. Child: 5-60 mg Over 50 kg:5-100 mg Focalin, child: mg Over 50 kg: mg. Focalin: 4-5 hrs. MEDICATIONS FOR ADHD Group Main Use Medication Brand/ Form Dose Schedule Dose Range Most Common Side Effects for Group Pros for Group Cautions for Group methylphenidate Methylin Focalin (dexmethylphenidate)

More information

Psychobiology Handout

Psychobiology Handout Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are

More information

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:

More information

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,

More information

ADHD Medications Table

ADHD Medications Table Stimulants are the first line treatment of choice for ADHD followed by Non-Stimulants, then off-label medications. We are providing this list of medications so that you can be familiar with the common

More information

Behavioral Health. Behavioral Health. Prescribing Guidelines

Behavioral Health. Behavioral Health. Prescribing Guidelines Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine

More information

The Use of ADHD Medication in the Pediatric Population

The Use of ADHD Medication in the Pediatric Population The Use of ADHD Medication in the Pediatric Population Shirin Madzhidova, PharmD Pediatric Pharmacotherapy Fellow Nova Southeastern University Objectives Discuss the importance of treatment with medications

More information

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

Psychiatry curbside: Answers to a primary care doctor s top mental health questions Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing

More information

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed

More information

Mixing and Matching: Layering Medications as Family Physicians

Mixing and Matching: Layering Medications as Family Physicians Mixing and Matching: Layering Medications as Family Physicians Family Medicine Forum Vancouver, B.C. November 9-12, 2016. Jon Davine, CCFP, FRCP(C) McMaster University Objectives Discuss different examples

More information

Treating Depression in Adults

Treating Depression in Adults Treating Depression in Adults By Deborah Christensen, Ph.D., M.S.C.P. Depressive Disorders represent a broad and heterogeneous group of commonly diagnosed psychological disorders. The DSM adequately describes

More information

Autism: Improving Health Care Outcomes

Autism: Improving Health Care Outcomes AUTISM AWARESS CONFERENCE Lewis County Autism Coalition 23 September 2011 Autism: Improving Health Care Outcomes Glenn C. Tripp, M.D. Developmental Behavioral Pediatrics Medical Director, Developmental

More information

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For

More information

Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE

Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE Chan-Hyung Kim, MD Severance Mental Health Hospital Institute of Behavioral Science in Medicine Diagnostic Criteria Pyramid Etiologic Pathophysiologic

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

Psychotropic Medications in Children and Adolescents: Guide for Use and Monitoring

Psychotropic Medications in Children and Adolescents: Guide for Use and Monitoring Psychotropic Medications in Children and Adolescents: Guide for Use and This document was developed by Community Care of North Carolina with the assistance of the Medication Management Workgroup of the

More information

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free

More information

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For

More information

ADHD and. Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry

ADHD and. Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry ADHD and Beyond Shaw Wendi Fortuchang, M.D. Board certified in Child & Adolescent, Adult, and Forensic Psychiatry Overview Use of medications in children How do medications work in the brain? Risperdal?

More information

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Change Your Brain, Change Your Life The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Daniel G Amen Three Rivers Press New York Appendix Medication 1.

More information

PSYCHIATRY INTAKE FORM

PSYCHIATRY INTAKE FORM Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.

More information

New Patient Questionnaire

New Patient Questionnaire 4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with

More information

Introductory discussion

Introductory discussion Billina R. Shaw, MD Assistant Professor University of Maryland School of Medicine Department of Psychiatry Division of Child and Adolescent Psychiatry Introductory discussion Prescribing trends in foster

More information

Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information

Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information Adderall and Adderall-XR (amphetamine mixtures) Concerta (methylphenidate, controlled Dexedrine, Dexedrine Spansules (dextroamphetamine) Focalin (dexmethylphenidate) Metadate, Metadate-ER, and Metadate-CD

More information

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.

More information

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious

More information

Primary Care Management of Depression. John Briles, MD, Medical Director October 11, 2017

Primary Care Management of Depression. John Briles, MD, Medical Director October 11, 2017 John Briles, MD, Medical Director October 11, 2017 Molina Healthcare of Michigan uses a HEDIS measure for Antidepressant Medication Management (AMM) to measure how well treating providers (PCPs) appropriately

More information

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA *We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening

More information

Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016

Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Pediatric Psychopharmacology: Erika Ryst, M.D. October 12, 2016 Good psychopharmacology depends on Proper use of safe and effective meds Treatment of other obvious factors (e.g., medical conditions, toxic

More information

Norpramin (desipramine)

Norpramin (desipramine) Generic name: Desipramine Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets Available in generic: Yes Drug class: Tricyclic antidepressant General Information Norpramin (desipramine)

More information

Mental illness A Broad Overview. Dr H Pathmanandam March 2017

Mental illness A Broad Overview. Dr H Pathmanandam March 2017 Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate

More information

Antidepressant Pharmacology An Overview

Antidepressant Pharmacology An Overview Figure 1. Antidepressant Pharmacology An Overview Source: NEJM 2005;353:1819-34 Figure 2. 1 Figure 3: Antidepressant Pharmacology pictures: Weak inhibition Bupropion NOTE: CYP enzymes noted are those inhibited

More information

Common Antidepressant Medications for Adults

Common Antidepressant Medications for Adults (and Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) Fluoxetine Weekly (Prozac Weekly) 20 in AM w/ food (10 mg in elderly or those w/ panic disorder) 20 40 40 (If age >60yo, max 20) 10 10

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents DRUG NAME INDICATIONS / ACCEPTABLE USES PRIOR STIMULANT/ADHD DRUGS Daytrana (methylphenidate) ADHD

More information

Medications, By Class, in TBI

Medications, By Class, in TBI Medications, By Class, in TBI Generic/Brand Name Drawback Advantage Mood Stabilizers (anti-seizure medications) Carbamazepine (Carbatrol ) (Equetro ) (Tegretol ) Gabapentin (Neurontin ) Lamotrigine (Lamictal

More information

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE: DYANAVEL XR (amphetamine) extended-release oral suspension Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018 MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES Holly Altenberger, PharmD, RPh Director of Pharmacy O Connell Pharmacy holly@oconnellpharmacy.com Objectives At the conclusion of the

More information

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected. KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised

More information

med ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.

med ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors. med ed Dr. Andrea Murphy, Assistant Professor, School of Nursing, Dalhousie University; Research Associate, Sun Life Financial Chair in Adolescent Mental Health Dr. David Gardner, Associate Professor,

More information

Facts about ADHD drugs as treatment

Facts about ADHD drugs as treatment Facts about ADHD drugs as treatment Common ADHD drugs as treatment Medication Stimulants Methylphenidate Dexmethylphenidate Amphetamine Non-Stimulants Straterra Guanfacine ER (Intuniv) Clonidine (Kapvay)

More information

Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion)

Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion) Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion) Generic name: Bupropion Available strengths: 75 mg, 100 mg immediate-release tablets; 100 mg, 150 mg, 200 mg sustained-release tablets (Wellbutrin-SR);

More information

Treatment Options for Bipolar Disorder Contents

Treatment Options for Bipolar Disorder Contents Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

ADHD Part II: Managing Comorbities

ADHD Part II: Managing Comorbities ADHD Part II: Managing Comorbities Brett Johnson, MD Staff Psychiatrist Rady Children s Behavioral Crisis Center Assistant Clinical Professor (Voluntary), UCSD January 26, 2011 Financial Disclosure I have

More information

TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE

TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE trazodone TOP APS DRUGS TRAZODONE BRAND NAMES: OLEPTRO, DESYREL (DIVIDOSE) & TRIALODINE Pharmacodynamics study of what a drug does to the body Studies show that trazodone selectively inhibits neuronal

More information

2013 Virtual AD/HD Conference 1

2013 Virtual AD/HD Conference 1 Medication for & Coexisting Conditions Part 2 Dr. Kenny Handelman Child, Adolescent & Adult Psychiatrist Halton Healthcare Adjunct Professor of Psychiatry, University of Western Ontario www.drkenny.com

More information

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA CASE #1 PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA OBJECTIVES Epidemiology Presentation in older adults Assessment Treatment

More information

Kelly Godecke, MD Department of Psychiatry University of Utah

Kelly Godecke, MD Department of Psychiatry University of Utah Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

Elavil (amitriptyline)

Elavil (amitriptyline) Generic name: Amitriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets; 10 mg/ml injection Available in generic: Yes Drug class: Tricyclic antidepressant General Information

More information

Psychopharmacology: An Overview

Psychopharmacology: An Overview Psychopharmacology: An Overview John Tanquary, M.D. Clinical Assistant Professor Department of Psychiatry Upstate Medical University Psychpharmacology Consultant Le Moyne College Syracuse University Financial

More information